The Drug Controller General of India (DCGI) has granted a test licence to 14 private companies, including Swiss firm Roche Diagnostics India, to evaluate the quality of testing kits for detecting coronavirus (Covid-19).

The companies, including CoSara Diagnostics and CPC Diagnostics, will evaluate the quality of test kits and submit their data to the drug regulator.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

According to the Indian Council of Medical Research (ICMR), Covid-19 tests will be conducted by accredited private labs to improve capacity for diagnosis and detection of the virus as the number of positive cases is growing.

DCGI granted the licence to Roche Diagnostics India for its cobas SARS CoV-2 diagnostic test kit.

Earlier this week, the Union Health Ministry of India issued guidelines for private sector laboratories who intend to initiate testing for the virus, while the ICMR appealed them to conduct the tests free of cost.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact